| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income (loss) before income taxes | -110,538 | -104,308 | -1,692 | -117,022 |
| Income tax benefit (expense) | -331 | 62 | 196 | -590 |
| Income (loss) from continuing operations | -110,207 | -104,370 | -1,888 | -116,432 |
| Income (loss) before gain (loss) on sales | 0 | 0 | - | -1,183 |
| Adjustments on sale of assets, net | 0 | 0 | 14,000 | - |
| Total discontinued operations | 0 | 0 | 14,000 | -1,183 |
| Net income (loss) | -110,207 | -104,370 | 12,112 | -117,615 |
| Noncontrolling interests share in (earnings) loss | 0 | 0 | - | - |
| Net income (loss) attributable to common shares | -110,207 | -104,370 | 12,112 | -117,615 |
| Weighted average shares outstanding basic (in shares) | 414,465,000 | 413,836,000 | 412,936,000 | 411,591,000 |
| Weighted average shares outstanding diluted (in shares) | 414,465,000 | 413,836,000 | 412,936,000 | 411,591,000 |
agilon health, inc. (AGL)
agilon health, inc. (AGL)